These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 20156065)
1. Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model. Yuan Z; Ledesma KR; Singh R; Hou J; Prince RA; Tam VH J Infect Dis; 2010 Mar; 201(6):889-97. PubMed ID: 20156065 [TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii. Lim TP; Ledesma KR; Chang KT; Hou JG; Kwa AL; Nikolaou M; Quinn JP; Prince RA; Tam VH Antimicrob Agents Chemother; 2008 Aug; 52(8):2898-904. PubMed ID: 18505848 [TBL] [Abstract][Full Text] [Related]
3. Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Hirsch EB; Guo B; Chang KT; Cao H; Ledesma KR; Singh M; Tam VH J Infect Dis; 2013 Mar; 207(5):786-93. PubMed ID: 23242537 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic/pharmacodynamic assessment of the in-vivo efficacy of imipenem alone or in combination with amikacin for the treatment of experimental multiresistant Acinetobacter baumannii pneumonia. Bernabeu-Wittel M; Pichardo C; García-Curiel A; Pachón-Ibáñez ME; Ibáñez-Martínez J; Jiménez-Mejías ME; Pachón J Clin Microbiol Infect; 2005 Apr; 11(4):319-25. PubMed ID: 15760430 [TBL] [Abstract][Full Text] [Related]
5. Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae. Mimoz O; Jacolot A; Padoin C; Tod M; Samii K; Petitjean O J Antimicrob Chemother; 1998 Mar; 41(3):367-72. PubMed ID: 9578163 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. Aoki N; Tateda K; Kikuchi Y; Kimura S; Miyazaki C; Ishii Y; Tanabe Y; Gejyo F; Yamaguchi K J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of human-simulated bronchopulmonary exposures of cefepime, zidebactam and the combination (WCK 5222) against MDR Pseudomonas aeruginosa in a neutropenic murine pneumonia model. Kidd JM; Abdelraouf K; Nicolau DP J Antimicrob Chemother; 2020 Jan; 75(1):149-155. PubMed ID: 31641765 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii. Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842 [TBL] [Abstract][Full Text] [Related]
9. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [TBL] [Abstract][Full Text] [Related]
10. In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology. Kresken M; Körber-Irrgang B; Läuffer J; Decker-Burgard S; Davies T Int J Antimicrob Agents; 2011 Jul; 38(1):70-5. PubMed ID: 21514795 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model. Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761 [TBL] [Abstract][Full Text] [Related]
12. Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam. Pachón-Ibáñez ME; Fernández-Cuenca F; Docobo-Pérez F; Pachón J; Pascual A J Antimicrob Chemother; 2006 Sep; 58(3):689-92. PubMed ID: 16870647 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response. Jacqueline C; Roquilly A; Desessard C; Boutoille D; Broquet A; Le Mabecque V; Amador G; Potel G; Caillon J; Asehnoune K J Antimicrob Chemother; 2013 Jan; 68(1):177-83. PubMed ID: 22941899 [TBL] [Abstract][Full Text] [Related]
14. Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo. Mimoz O; Jacolot A; Padoin C; Caillon J; Louchahi K; Tod M; Samii K; Petitjean O J Antimicrob Chemother; 1997 Mar; 39(3):363-9. PubMed ID: 9096186 [TBL] [Abstract][Full Text] [Related]
15. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Kwa AL; Loh C; Low JG; Kurup A; Tam VH Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101 [TBL] [Abstract][Full Text] [Related]
16. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics. Burgess DS; Frei CR J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664 [TBL] [Abstract][Full Text] [Related]
17. Joint Intratracheal Surfactant-Antibacterial Therapy in Experimental Pseudomonas-Induced Pneumonia. Birkun AA; Kubyshkin AV; Novikov NY; Krivorutchenko YL; Fedosov MI; Postnikova ON; Snitser AA J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):299-307. PubMed ID: 25517041 [TBL] [Abstract][Full Text] [Related]
18. n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa. Giamarellos-Bourboulis EJ; Mouktaroudi M; Adamis T; Koussoulas V; Baziaka F; Perrea D; Karayannacos PE; Giamarellou H Antimicrob Agents Chemother; 2004 Dec; 48(12):4713-7. PubMed ID: 15561848 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp. Sader HS; Jones RN Int J Antimicrob Agents; 2005 May; 25(5):380-4. PubMed ID: 15848291 [TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Zavascki AP; Carvalhaes CG; Picão RC; Gales AC Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]